DRKS00012848
Completed
未知
Validation of a non-invasive in-ear sensor for oxygen saturation, heart rate and body core temperature measurement - PhyLDS-0
niversitätsklinikum Schleswig-Holstein Campus Lübeck0 sites10 target enrollmentAugust 9, 2017
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Validation measurement accuracy of a non-invasive in-ear sensor for body temperature, heart rate and oxygen saturation
- Sponsor
- niversitätsklinikum Schleswig-Holstein Campus Lübeck
- Enrollment
- 10
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\= 18 years
- •Citizen of the European Union
- •Open thoracic surgery
Exclusion Criteria
- •Limitation to consent
- •ear anomaly
Outcomes
Primary Outcomes
Not specified
Similar Trials
Withdrawn
Not Applicable
Validation of In-Ear SensorBiometrics MeasurementNCT04680871Starkey Laboratories, Inc
Recruiting
Not Applicable
Clinical trial of the non-invasive pulseoxymeter and respiratory rate monitering for post-operative patients.patients undergoing surgeryJPRN-UMIN000008329Jichi Medical University300
Not yet recruiting
Phase 1
The In vivo assessment of a thermoresponsive otic gel in healthy individuals. Phase 1 trial.Otitis ExternaACTRN12618001517268niversity of Queensland 15
Completed
Not Applicable
Efficacy of a wearable biosensor for patients with COVID-19 or cardiopulmonary diseasesi) SARS-CoV-2 PCR positive COVID-19 patient ii) Heart failure iii) Sleep apnea syndrome iv) Asthma v) Chronic obstructive pulmonary disease vi) Intestinal pneumonia vii) Pulmonary mycobacterium avium complex disease viii) Pediatric inguinal hernia ix) Congenital cystic disease of lung x) Pediatric metastatic lung tumors xi) PneumoniaJPRN-UMIN000043546Innovative Clinical Research Center, Kanazawa University, Kanazawa, Japan20
Recruiting
Not Applicable
Checking the effectiveness of a new hearing assessment (Oto-acoustic Emission) in identifying hearing loss caused due to Cisplatin (widely used as part of cancer treatment) in adult cancer patients.Health Condition 1: C00-C14- Malignant neoplasms of lip, oral cavity and pharynxCTRI/2023/12/060500Tata Research Administrative Council